Transitional cell carcinoma expresses high levels of Fas ligand in vivo.

In vivo expression of soluble Fas and FAP-1: possible mechanisms of Fas resistance in human hepatoblastomas

Alterations of Fas (APO/CD95) gene in non-small cell lung cancer

alterations of Fas (APO-1/CD95) gene in cutaneous malignant melanoma

alterations of Fas (APO-1/CD95) gene in transitional cell carcinomas of urinary bladder

Detection of Soluble Fas mRNA using in Situ Reverse Transcription-polymerase Chain Reaction

Fas Ligand is Expressed in Normal and Malignant Squamous Epithelium of the Skin

Immunohistochemical Analysis of Fas Ligand Expression in Sarcoma

Spatial architectures of somatic mutations in normal prostate, benign prostatic hyperplasia and coexisting prostate cancer

Single-cell RNA sequencing reveals a pro-metastatic subpopulation and the driver transcription factor NFE2L1 in ovarian cancer cells